EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Torque teno virus as a marker of immune status in immunocompromised patients: A systematic review

Janaina B Medina iD, Fábio França Vieira E Silva iD, Rafael Antônio Velôso Caixeta iD, Bruna de Oliveira Rech iD, Alba Perez-Jardón iD, María Elena Padín-Iruegas iD, Mario Pérez-Sayáns iD, Paulo Henrique Braz-Silva iD, Karem L Ortega iD

European Journal of Clinical Investigation · 2025

DOI: 10.1111/eci.70068 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Clinical Investigation, 2025. Verfasst von Janaina B Medina und 8 weiteren Autor:innen. Beteiligte Einrichtung: Oral Medicine, Oral Surgery and Implantology Unit (MedOralRes), Faculty of Medicine and Dentistry, University of Santiago de Compostela, Santiago de …. Hauptthemen laut MEDLINE: DNA Virus Infections, Immunocompromised Host, Torque teno virus. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pro-Reitoria de Pesquisa, Universidade de São Paulo, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Torque teno virus (TTV) is not known to cause disease in humans; however, chronic inflammatory conditions and immunosuppression states can favour TTV replication. This study aimed to verify the effectiveness of TTV as an immune biomarker.

Methods

The protocol of this review was registered in PROSPERO (CRD42022331049) and performed according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines.

Results

Thirty‐three articles were selected and different groups of patients were assessed. In the solid organ and hematopoietic stem cell transplant groups, most studies reported that TTV viral load (VL) was highly detectable after transplantation and compared to controls, but the association with immune parameters showed conflicting results. In melanoma patients, no statistical difference in TTV VL was identified between susceptible and treatment‐resistant patients. In lung cancer patients, viral load increases significantly with disease progression but decreases after chemotherapy. HIV‐positive patients showed a higher VL than controls, but an inverse correlation with CD4+ was observed in half of the studies. Although 57.14% of all studies presented a low risk of bias, significant differences were observed between studies, particularly in the choice of the analyzed outcome, the parameter used to evaluate the patient's immune status, the presence of a control group, and the sample collection time points.

Conclusions

Although TTV seems to have the potential to be a promising biomarker of immunosuppression, further high‐quality prospective clinical studies are still needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Virus InfectionsImmunocompromised HostTorque teno virusHumansBiomarkersHematopoietic Stem Cell TransplantationOrgan TransplantationViral Load

Stichwörter der Autor:innen

biomarkerimmunosuppressionprognosistorque teno virustransplantation

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Oral Medicine, Oral Surgery and Implantology Unit (MedOralRes), Faculty of Medicine and Dentistry, University of Santiago de Compostela, Santiago de Compostela, Spain.
  • ORALRES Group, Health Research Institute of Santiago de Compostela (FIDIS), Santiago de Compostela, Spain.
  • Department of Stomatology, School of Dentistry, University of São Paulo, São Paulo, Brazil.
  • Human Anatomy Area, University of Vigo, Vigo, Spain.
  • Laboratory of Virology, Institute of Tropical Medicine, School of Medicine, University of São Paulo, São Paulo, Brazil.

ORCID-Profile: Janaina B Medina, Fábio França Vieira E Silva, Rafael Antônio Velôso Caixeta, Bruna de Oliveira Rech, Alba Perez-Jardón, María Elena Padín-Iruegas, Mario Pérez-Sayáns, Paulo Henrique Braz-Silva, Karem L Ortega

Förderung

  • Pro-Reitoria de Pesquisa, Universidade de São Paulo
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Medina, J. B., França Vieira E Silva, F., Caixeta, R. A. V., de Oliveira Rech, B., Perez-Jardón, A., Padín-Iruegas, M. E., Pérez-Sayáns, M., Braz-Silva, P. H., & Ortega, K. L. (2025). Torque teno virus as a marker of immune status in immunocompromised patients: A systematic review. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70068

Vancouver

Medina JB, França Vieira E Silva F, Caixeta RAV, de Oliveira Rech B, Perez-Jardón A, Padín-Iruegas ME, et al. Torque teno virus as a marker of immune status in immunocompromised patients: A systematic review. European Journal of Clinical Investigation. 2025. doi:10.1111/eci.70068

BibTeX
@article{Medina2025,
  author = {Medina, Janaina B and França Vieira E Silva, Fábio and Caixeta, Rafael Antônio Velôso and de Oliveira Rech, Bruna and Perez-Jardón, Alba and Padín-Iruegas, María Elena and Pérez-Sayáns, Mario and Braz-Silva, Paulo Henrique and Ortega, Karem L},
  title = {Torque teno virus as a marker of immune status in immunocompromised patients: A systematic review},
  journal = {European Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1111/eci.70068}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche